Work

Abstract B133: Characterization of FDA Regulatory Designations and Trial Models for Rare Cancer Approvals (2012–2022)

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b133

Authors: Tariq E. Alzahrani, Albandari A. Alnasser, Alhanouf Y. Alnafisah, Aljawharah A. Albati, Manal F. Almutairi, Meshal A. Al-Kalabi, Shatha A. Almuhaidib, Tariq H. Alqurayshah

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444222

Cites:

Cited by:

Related to: